Guidelines for risk stratification after myocardial infarction

Annals of Internal Medicine

Volumn 126, Issue 7, 1997, Pages 556-560

  Peterson, E D ^a   Shaw, L J ^a   Califf, R M ^a   Thibault, G E ^a   Feussner, J R ^a   Audet, A M J ^a   Friesenger G C , Jr ^a   Kent, D L ^a   Marton, K J ^a   Palda, V A ^a   Whyte, J J ^a   Winters, P L ^a  

^a AMERICAN COLLEGE OF PHYSICIANS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY CARE UNIT; HEALTH CARE QUALITY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL CARE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 14444269005     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-7-199704010-00011     Document Type: Review

References (11)

1. DeBusk RF. Specialized testing after recent acute myocardial infarction. Ann Intern Med. 1989;110:470-81.
2. Pashos CL, Newhouse JP, McNeil BJ. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990 JAMA 1993;270:1832-6
3. Jollis JG, Peterson ED, Bebchuk JD, DeLong ER, Humphries JO, Muhlbater LH, et al. Coronary angioplasty in 20,006 patients over age 80 in the United States [Abstract]. J Am Coll Cardiol. 1995;25:47A.
4. Gurwitz JH, Gore JM, Goldberg RJ, Rubison M, Chandra N, Rogers WJ, et al. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction. Ann Intern Med. 1996;124:283-91
5. Newby LK, Califf RM, Guerci A, Weaver WD, Col J, Morgan JH, et al. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol. 1996;27:625-32.
6. Epstein AE, Hallstrom AP, Rogers WJ, Liebson PR, Seals AA, Anderson JL, et al. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA. 1993;270: 2451-5.
7. Randomised trial of intravenous atenoiol among 16027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet. 1986,1:57-66.
8. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis In myocardial infarction (TIMI) phase II trial. The TIMI Study Group. N Engl J Med. 1989;320:618-27.
9. Ellerbeck EF, Jencks SF, Radford MJ, Kresowik TF, Craig AS, Gold JA, et al. Quality of care for Medicare pattents with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995;273:1509-14
10. Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 1987;317:581-8.
11. Brodie B, Grines CL, Spain M, Griffin J, Balestrini C, Stone GW, et al. A prospective, randomized trial evaluating early discharge (day 3) without non-invasive risk stratification in low-risk patients with acute myocardial infarction: PAMI-2 [Abstract]. J Am Coll Cardiol. 1995;25:5A.